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Enveloped viruses enter target cells by membrane
fusion or endocytosis. In the latter case, fusion of the
viral envelope is induced by the acidic pH of the
endocytic vesicle [1]. As with most other retroviruses,
entry of the human immunodeficiency virus (HIV) is
thought to be exclusively by pH-independent membrane
fusion after interaction of its envelope with CD4 and a
chemokine co-receptor on the target cell [2,3].
Expression of CD4 on the virus-producing cell impairs
the release and infectivity of HIV-1NL4-3 particles [4–6].
In sharp contrast, we found that the infectivity of
another HIV isolate, HIV-1SF2, was enhanced by
expression of CD4 on the producer cells, which
correlated with significantly increased amounts of viral
proteins in the vesicular fraction of target cells.
Endocytic inhibitors decreased infectivity of HIV-1SF2
but enhanced that of HIV-1NL4-3. Expression of CD4 in
the producer cell did not remove gp41 from HIV-1SF2
virions. With these cells, the formation of syncytia could
be induced by acidic medium. Thus, HIV-1SF2 can enter
the cytoplasm by an endocytic route after activation of
gp41 by the acidic pH of endocytic vesicles. Endocytic
entry might expand the range of cells that HIV could
infect and should be considered in antiviral strategies
against AIDS.
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Results and discussion
The reduction of CD4 expression on the surface of pro-
ducer cells by the HIV proteins Nef and Vpu is thought to
prevent superinfection by other virions. It could also opti-
mize viral production or infectivity by counteracting nega-
tive effects of CD4 on the viral envelope [4–6]. We have
compared the effects of CD4 on two distinct isolates,
HIV-1NL4-3 and HIV-1SF2. Proviral DNA was transfected
into 293T cells in the absence or presence of a CD4
expression plasmid (Figure 1, white and black bars) and
culture supernatants were harvested 48 hours later. No
significant change in the amount of reverse transcriptase
activity released into the supernatant was observed in the
presence of CD4 (Figure 1a). This suggested that concen-
trations of CD4  were not sufficient to block particle
release [5]. When, however, the relative infectivity of
released particles was tested in an assay of a single round
of replication in HeLa–CD4–β-galactosidase (Sx22-1)
indicator cells, CD4 expression significantly reduced the
relative infectivity of HIV-1NL4-3 to 30% of that in the
absence of CD4 (Figure 1b, left panel). These results are
consistent with published data [6]. In sharp contrast, the
relative infectivity of HIV-1SF2 was increased more than
twofold in the presence of CD4 (Figure 1b, right panel).
Notably, the absolute infectivity was up to 10-fold higher
for HIV-1NL4-3 than for HIV-1SF2. Thus, depending on
the viral isolate, the expression of CD4 on the producer
cell can be deleterious or beneficial to HIV-1 infectivity.
To identify the cause of the different responses of
HIV-1NL4–3 and HIV-1SF2 to CD4, we tested the subcel-
lular distribution of viral proteins in target cells shortly
after infection. When Jurkat cells were fractionated, about
60% of the internalized p24Gag protein from HIV-1NL4-3
was detected in the cytosolic fraction (Figure 2). This ratio
between vesicular and cytosolic p24Gag is identical to data
for HIV-1NL4-3 with CEM cells [7]. HIV-1NL4-3 virions
produced in the presence of CD4 displayed a similar sub-
cellular distribution (Figure 2). For HIV-1SF2, however,
only 35–40% of the viral protein was present in the
cytosol, suggesting that relatively more HIV-1SF2 was
endocytosed. Interestingly, HIV-1SF2 virions produced in
the presence of CD4 were found almost exclusively (95%)
Figure 1
The expression of CD4 in the producer cell has opposite effects on the
infectivity of HIV-1NL4-3 and HIV-1SF2. Culture supernatants from 293T
cells transfected with proviral DNA in the absence (white bars) or
presence (black bars) of a CD4 expression vector were assayed for
(a) the amount of RT activity and (b) the relative infectivity of virions
produced in a single round of replication. Values in the absence of
CD4 were arbitrarily set to 100% for both viruses. Data are average
values from at least three independent experiments with standard
errors of the mean.
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in the vesicular fraction of target cells (Figure 2). This dis-
tribution was similar to that of non-infectious HIV-1NL4-3
lacking the env gene ([7], and data not shown). For
HIV-1SF2, however, this shift towards the vesicular frac-
tion correlated with increased infectivity (Figure 1b). We
conclude that HIV-1SF2 can productively enter target cells
through endocytic vesicles. As the percentage of the input
virus recovered was similar for HIV-1NL4-3 and HIV-1SF2,
yet HIV-1NL4-3 displayed a consistently higher relative
infectivity, the entry of HIV-1SF2 via endocytosis was less
efficient than the entry of HIV-1NL4-3 by fusion.
To confirm that HIV-1SF2 can infect target cells via endo-
cytosis, we performed assays of a single round of replica-
tion in the presence of endocytic inhibitors. By blocking
acidification of endocytic vesicles [8], NH4Cl and con-
canamycin A inhibit viral entry via endocytosis. As previ-
ously described [9], the infectivity of HIV-1NL4-3 was
increased in the presence of NH4Cl and concanamycin A
by 40–80%, respectively (Figure 3a, HIV-1NL4-3). These
endocytic inhibitors increased even more the infectivity of
HIV-1NL4-3 particles produced in the presence of CD4
(Figure 3a, HIV-1NL4-3 + CD4). In sharp contrast, the
infectivity of HIV-1SF2 was decreased by up to 50% in the
presence of both compounds (Figure 3a, HIV-1SF2).
Although the concentrations of inhibitors used completely
blocked endocytic entry mediated by the G protein of
vesicular stomatitis virus (VSV-G) ([9], data not shown),
the infectivity of HIV-1SF2 was not completely abolished
under these conditions. The infectivity of HIV-1SF2 virions
produced in the presence of CD4 was, however, reduced
by 95% (Figure 3a, HIV-1SF2 + CD4). We conclude that
HIV-1SF2 can infect target cells successfully by an endo-
cytic mechanism and that HIV-1SF2 virions produced in
the presence of CD4 use this route almost exclusively for
entry into HeLa cells.
For viruses that enter cells by the endocytic route, fusion
is induced by the low pH of the endocytic vesicles [1].
This event can be mimicked by incubating producer cells
in acidic medium, which typically results in the formation
of syncytia. Consistent with its ability to enter cells by
receptor-mediated fusion, no differences were observed in
the formation of syncytia at pH 7 and pH 5 in HIV-1NL4-3-
producing HeLa–CD4–β-galactosidase indicator (P4) cells
(Figure 3b, top panel). Large syncytia containing a
maximum of 45 nuclei (average 15) were observed at
either pH. No syncytia were formed in cells transfected
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Figure 2
HIV-1SF2 is present in significantly higher amounts than HIV-1NL4-3 in
the vesicular fraction of target cells. p24Gag (100 ng) of the respective
viruses produced in the absence or presence of CD4 were incubated
with Jurkat cells which were then lysed and separated into cytosolic
(white bars) and vesicular (black bars) fractions as described in
Materials and methods. The amount of p24Gag in each fraction was
determined by ELISA. The relative distribution of p24Gag between the
cytosolic and vesicular fractions is presented. The ratio between
cellular and vesicular p24Gag was constant over one order of
magnitude of the amount of input virus. The total amount of captured
protein after fractionation ranged between experiments from 0.1–1%
of input protein without a change of the relative p24Gag distribution.
Average values from at least three independent experiments are given
with standard errors of the mean.
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Figure 3
Acidification of endocytic vesicles is required for optimal infectivity of
HIV-1SF2. (a) Virus stocks of HIV-1NL4-3 and HIV-1SF2 produced in the
absence or presence of CD4 were assayed for infectivity in a single
round of replication in the absence (white bars) or presence of
10 mM NH4Cl (gray bars) or 25 nM concanamycin A (black bars),
respectively. Relative infectivities in the absence of inhibitors were
arbitrarily set to 100% for all viruses. Average values from at least three
independent experiments are given with standard errors of the mean.
(b) P4 cells transfected with the indicated molecular clones were treated
for 5 min with medium adjusted to pH 7 (left panel) or pH 5 (right panels)
and monitored for the presence of syncytia after an additional incubation
for 1 h in regular medium. Syncytia are indicated by arrows.
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with an empty control plasmid vector at either pH (data
not shown). In sharp contrast, and although occasional het-
erokaryons were observed at neutral pH, large syncytia
were detected only at pH 5 with HIV-1SF2 (Figure 3b,
bottom panel). With both strains of HIV-1 in permissive
conditions the number of syncytia were equivalent. The
pH-induced polynuclei formed with HIV-1SF2 were
smaller than those with HIV-1NL4-3 and contained up to
18 nuclei (average 8). The induction of fusion by low pH
was similar but less pronounced than with VSV-G (data
not shown). These results show that the fusogenic activity
of HIV-1SF2 can be induced by low pH and confirm that
endocytosis is its preferred route of entry into HeLa cells.
Previous results suggested that HIV-1SF2 can fuse from
endocytic vesicles and that the presence of CD4 in the
producer cells enhances this activity. Because it has been
reported that CD4 drastically reduces the amount of Env
in the HIV-1NL4-3 virion [6], we analyzed the composition
of virions produced in the presence or absence of CD4.
293T cells were co-transfected with our proviruses and a
CD4 expression plasmid or an empty control plasmid
vector. Cells were metabolically labeled and cell extracts
and virus pellets were immunoprecipitated with serum
from an AIDS patient. Immunoprecipitations were sepa-
rated by SDS–PAGE, and proteins visualized by autoradi-
ography. As expected, expression of CD4 in the producer
cell resulted in significantly reduced incorporation of both
gp120 and gp41 into HIV-1NL4-3 virions (Figure 4, compare
lanes 6 and 8). In sharp contrast, gp41 was still abundant
in HIV-1SF2 virions produced in the presence of CD4
(Figure 4, lane 4). As the presence of CD4 reduced cleav-
age of the gp160 Env precursor to gp120 and gp41 to a
similar degree for HIV-1NL4-3 and HIV-1SF2, these differ-
ent virion compositions were not a consequence of altered
Env processing. Thus, whereas HIV-1NL4-3 virions do not
incorporate detectable amounts of viral Env in the pres-
ence of CD4, HIV-1SF2 virions still have gp41. Thus,
fusion of these virions out of endocytic vesicles could
result from the activation of gp41 by low pH. 
Our results demonstrate the existence of HIV-1 isolates
that can infect cells via an endocytic mechanism. Although
the ability of HIV to enter cells by clathrin-coated vesicles
had been documented by electron microscopy [10–12] and
HIV-1 replication can be sensitive to NH4Cl [13], we
provide the first evidence that this route of entry can lead
to viral integration and early gene expression. It also sug-
gests that the fusogenic activity of gp41 can be activated
by low pH similarly to the hemagglutinin protein of
influenza virus (see Supplementary material). Although
less efficient than receptor-mediated fusion, this endo-
cytic entry could expand the cellular range of HIV,
explain its CD4-independent entry [14] and reconcile
reports on the replication of HIV-1SF2 in CD4-negative
fibroblasts and glial cells [15]. By this mechanism, HIV
might also be able to create many more latent reservoirs,
which could represent a major challenge for the eradica-
tion of the virus. Moreover, this finding might be relevant
for future therapies of AIDS, where blocking CD4 and
chemokine receptors could select for ‘HIV-1SF2’ variants.
Rather, the main goal should be to block the fusion event
itself. To this end, several compounds directed against the
fusogenic activity of gp41 have been tested with encour-
aging results in vitro and in vivo [16,17].
Materials and methods
Cells, constructs and viruses
293T, Jurkat, Sx22-1 and P4 cells were cultured as described else-
where [18,19]. P4 cells were obtained from Ned Landau via the AIDS
Research and Reference Reagent Program. Infectious virus was gener-
ated by transfecting proviral DNA encoding complete molecular clones
into 293T cells using lipofectamine (Gibco) according to the manufac-
turer’s instructions. To produce virus in the presence of CD4, proviral
DNA was co-transfected with an expression plasmid for CD4 at 1:1
ratio. Molecular clones for HIV-1SF2 and HIV-1NL4-3 were described pre-
viously [20,21]. The expression construct for CD4 was kindly provided
by Rafick Sekaly, and the molecular clone lacking the env gene
(pNL LucR-E–) was obtained from Ned Landau via the AIDS Research
and Reference Reagent Program. Cell culture supernatants were har-
vested 48 h later, cleared through a 45 mm filter (Millipore) and stored
at –80°C or used directly in infectivity assays. The amounts of virus were
quantified by determining the reverse transcriptase activity according to
standard protocols or by p24Gag ELISA (NEN Life Science Products).
Infectivity assay
The relative infectivity of virus particles was assayed on the
HeLa–CD4–β-Gal indicator cell line Sx22-1 [19]. Sx22-1 cells were
infected in 96-well plates with virus stocks for 5 h and then cultured in
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Figure 4
Differential incorporation of Env proteins into HIV-1NL4-3 and HIV-1SF2
virions in the presence of CD4. 293T cells were transfected with
proviral DNA in the absence (lanes 1, 2, 5 and 6) or presence (lanes 3,
4, 7 and 8) of a CD4 expression plasmid, metabolically labeled, and
cellular lysates (c) as well as virus pellets (vp) were immunoprecipitated
with the serum from an AIDS patient. Presented is an autoradiogram of
these immunoprecipitations after the separation by a 10% SDS–PAGE.
The positions of viral proteins are given on the left. Note that only the
lower band in the panel of gp41 of HIV-1NL4-3 is specific.
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fresh medium for 36 h after which the cells were stained for β-galac-
tosidase and the blue cells were counted. Numbers of blue cells per
well ranged from 200 to 300 for HIV-1NL4-3, 40 to 70 for HIV-1NL4-3
produced in the presence of CD4, 20 to 50 for HIV-1SF2 and 50 to
200 for HIV-1SF2 produced in the presence of CD4. The relative infec-
tivity was calculated as the number of blue cells divided by the reverse
transcriptase activity of the respective virus stock. To determine the
effects of endocytic inhibitors on viral infectivity, the 5 h infections
were performed in the presence of 10 mM NH4Cl and 25 nM con-
canamycin A followed by cultivation of cells in normal medium. Similar
results were obtained when endocytic inhibitors were present for as
little as 1 h, showing that the observed effects were not due to non-
specific effects of the drugs.
Fusion assay
P4 cells (5 × 104) were plated on coverslips overnight and transfected
with proviral DNA using lipofectamine (Gibco). Twenty-four hours after
transfection, the cells were incubated with prewarmed culture medium
adjusted to pH 5 or pH 7, for 5 min at 37°C and then grown for another
1 h in regular culture medium. Cells were then fixed, stained with 1%
methylene blue in methanol, washed in PBS and analyzed for the pres-
ence of syncytia.
Cell fractionation
Separation of cells into cytosolic and vesicular fractions was performed
essentially as described in [7]. Briefly, 1 × 107 Jurkat cells were incu-
bated for 30 min rocking at 4°C with virus stocks containing 100 ng
p24Gag in a total volume of 1 ml DMEM containing 20 mM HEPES,
pH 7.0 and 20 µg/ml DEAE dextran. After extensive washing with PBS,
attached virus was allowed to enter cells for 1 h at 37°C followed by
digestion of uninternalized particles by pronase (0.1 mg/ml, 2 min,
4°C). Pronase treatment was stopped by the addition of FCS. No
background p24Gag protein was detected on cells that were treated
with pronase directly after incubation with virus stock. The cells were
then washed in PBS and incubated in swelling buffer (10 mM Tris-HCl,
pH 8.0, 10 mM KCL, 1 mM EDTA) for 1 min on ice, followed by homog-
enization by 5 dounce strokes. The post-nuclear supernatants were
ultracentrifuged (12 min, 50,000 rpm, SWTi55 rotor, 4°C) resulting in
the cytosolic supernatant and the vesicular pellet. The pellet was resus-
pended in 20 mM HEPES, 0.5% Triton X-100, 150 mM NaCl, the
cytosolic fraction adjusted to 0.5% Triton X-100 and the amounts of
viral protein in each fraction were determined by p24Gag ELISA.
Analysis of virus particles
To determine the composition of virions, 293T cells were transfected
with proviral DNA and metabolically labeled with 100 µCi [35S]Met,Cys
(Pro-Mix, Amersham Life Science) 36 h post-transfection for 8–12 h.
Cell supernatants were collected and virus pellets were generated by
ultracentrifugation (2 h, 100,000g, 4°C). Cells and virus pellets were
lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.2, 1%
Triton X-100, 0.1% SDS) for 30 min at 4°C and cleared supernatants
(10 min, 14,000g) were immunoprecipitated with serum from an AIDS
patient. After 3 h incubation, immunoprecipitates were washed three
times in RIPA buffer, separated on 10% SDS–PAGE and visualized by
autoradiography. 
Supplementary material
Supplementary material including a figure demonstrating opposite
effects of soluble CD4 on the infectivity of HIV-1NL4-3 and HIV-1SF2
and a model of endocytic entry by HIV-1 is available at http://current-
biology.com/supmat/supmatin.htm.
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